COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.

ABSTRACT:

Background

Cancer patients are at higher risk of COVID-19 complications and mortality than the rest of the population. Breast cancer patients seem to have better prognosis when infected by SARS-CoV-2 than other cancer patients.

Methods

We report a subanalysis of the OnCovid study providing more detailed information in the breast cancer population.

Results

We included 495 breast cancer patients with a SARS-CoV-2 infection. Mean age was 62.6 years; 31.5% presented more than one comorbidity. The most frequent breast cancer subtype was luminal-like (n = 245, 49.5%) and 177 (35.8%) had metastatic disease. A total of 332 (67.1%) patients were receiving active treatment, with radical intent in 232 (47.6%) of them. Hospitalization rate was 58.2% and all-cause mortality

SUBMITTER: Garrigos L 

PROVIDER: S-EPMC8573484 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature